SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
15-May-24 7:08 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 13-May-24 | Private Purchase | 30,000 | $5.55 | $166,500.00 | 3% 1.14M to 1.17M | |
04-Jan-24 4:31 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 03-Jan-24 | Gift | 20,000 | -- | -- | 2% 1.13M to 1.15M | |
04-Jan-24 4:31 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 03-Jan-24 | Gift | 20,000 | -- | -- | (2%) 1.15M to 1.13M | |
20-Dec-23 4:40 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-23 | Payment of Exercise | 14,089 | $6.05 | $85,238.50 | (1%) 1.15M to 1.13M | |
18-Dec-23 4:43 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Grant | 127,500 | -- | -- | 12% 1.03M to 1.16M | |
18-Dec-23 4:43 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-23 | Payment of Exercise | 13,592 | $6.43 | $87,396.60 | (1%) 1.16M to 1.15M | |
15-Jun-23 4:50 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 13-Jun-23 | Gift | 25,000 | -- | -- | (2%) 1.06M to 1.03M | |
23-Mar-23 4:40 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 21-Mar-23 | Option Exercise | 31,055 | $3.22 | $99,997.10 | 3% 1.03M to 1.06M | |
02-Feb-23 5:20 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Feb-23 | Option Exercise | 100,000 | $5.45 | $545,000.00 | 10% 1.03M to 1.13M | |
02-Feb-23 5:20 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Feb-23 | Planned Option Sale | 100,000 | $10.38 | $1,038,000.00 | (9%) 1.13M to 1.03M | |
05-Jan-23 1:11 PM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 03-Jan-23 | Option Exercise | 121,452 | -- | -- | 147% 82.63K to 204.09K | |
02-Feb-23 5:20 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 29-Dec-22 | Gift | 10,000 | -- | -- | < 1% 1.03M to 1.04M | |
02-Feb-23 5:20 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 29-Dec-22 | Gift | 10,000 | -- | -- | (< 1%) 1.04M to 1.03M | |
21-Dec-22 4:38 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Dec-22 | Grant | 127,500 | -- | -- | 14% 897.73K to 1.03M | |
19-Dec-22 5:09 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Dec-22 | Sale | 14,100 | $10.90 | $153,690.00 | (2%) 911.83K to 897.73K | |
02-Dec-22 6:33 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 02-Dec-22 | Option Exercise | 82,656 | $1.42 | $117,372.00 | 9% 911.83K to 994.49K | |
02-Dec-22 6:33 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 02-Dec-22 | Option Sale | 82,656 | $12.80 | $1,058,000.00 | (8%) 994.49K to 911.83K | |
02-Dec-22 6:33 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Dec-22 | Option Exercise | 214,917 | $1.42 | $305,182.00 | 24% 911.83K to 1.13M | |
02-Dec-22 6:33 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Dec-22 | Option Sale | 214,917 | $13.00 | $2,793,920.00 | (19%) 1.13M to 911.83K | |
02-Sep-22 10:26 AM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 01-Sep-22 | Option Exercise | 60,580 | -- | -- | 141% 43.11K to 103.69K | |
13-Jan-22 4:45 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 11-Jan-22 | Option Exercise | 184,000 | $4.73 | $870,320.00 | 20% 911.6K to 1.1M | |
13-Jan-22 4:45 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 11-Jan-22 | Option Sale | 184,000 | $15.04 | $2,767,360.00 | (17%) 1.1M to 911.6K | |
06-Jan-22 9:40 AM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 04-Jan-22 | Option Exercise | 21,504 | -- | -- | 2150% 1.0K to 22.5K | |
16-Dec-21 4:53 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 14-Dec-21 | Grant | 123,000 | -- | -- | 16% 788.6K to 911.6K | |
16-Dec-21 4:53 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Sep-21 | Gift | 10,000 | -- | -- | 1% 788.6K to 798.6K | |
16-Dec-21 4:53 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Sep-21 | Gift | 10,000 | -- | -- | (1%) 798.6K to 788.6K | |
17-Dec-20 4:20 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Dec-20 | Option Exercise | 134,278 | $4.15 | $557,254.00 | 17% 784.09K to 918.36K | |
17-Dec-20 4:20 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Dec-20 | Market Option Sale | 134,278 | $8.32 | $1,117,190.00 | (15%) 918.36K to 784.09K | 9% |
18-Nov-19 4:17 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 18-Nov-19 | Private Purchase | 50,000 | $1.45 | $72,500.00 | 7% 728.09K to 778.09K | |
03-Jan-19 4:27 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-19 | Payment of Exercise | 3,568 | $8.07 | $28,793.80 | (< 1%) 727.67K to 724.11K | 7% |
06-Dec-18 4:34 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 03-Dec-18 | Option Exercise | 80,000 | $1.20 | $96,000.00 | 11% 727.67K to 807.67K | |
06-Dec-18 4:34 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 03-Dec-18 | Market Option Sale | 80,000 | $9.12 | $729,600.00 | (10%) 807.67K to 727.67K | 17% |
13-Nov-18 4:01 PM View: | Bellicum Pharmaceuticals, Inc (BLCM) | 09-Nov-18 | Market Purchase | 10,000 | $4.56 | $45,600.00 | 100% 0 to 10.0K | (92%) |
21-May-18 9:31 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 17-May-18 | Option Exercise | 70,427 | $1.42 | $100,006.00 | 11% 655.09K to 725.52K | |
02-Mar-18 2:23 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 28-Feb-18 | Payment of Exercise | 43,224 | $4.97 | $214,823.00 | (6%) 698.32K to 655.09K | (52%) |
02-Mar-18 2:23 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 28-Feb-18 | Option Exercise | 56,949 | $3.26 | $185,654.00 | 9% 641.37K to 698.32K | |
23-Jan-18 9:03 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-18 | Payment of Exercise | 9,584 | $5.59 | $53,574.60 | (1%) 647.95K to 638.37K | (35%) |
03-Jan-18 8:59 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-18 | Payment of Exercise | 2,716 | $4.91 | $13,335.60 | (< 1%) 650.67K to 647.95K | (53%) |
24-Jan-17 9:17 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-17 | Payment of Exercise | 10,572 | $5.95 | $62,903.40 | (2%) 655.99K to 645.42K | (27%) |
03-Jan-17 1:59 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-17 | Payment of Exercise | 8,595 | $6.33 | $54,406.30 | (1%) 664.59K to 655.99K | (19%) |
03-Mar-16 9:41 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-16 | Payment of Exercise | 2,761 | $2.13 | $5,880.93 | (< 1%) 667.35K to 664.59K | (253%) |
22-Jan-16 9:16 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-16 | Payment of Exercise | 10,624 | $7.55 | $80,211.20 | (2%) 676.33K to 665.7K | < 1% |
21-Jan-16 1:12 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-16 | Option Exercise | 24,096 | $4.15 | $99,998.40 | 4% 652.23K to 676.33K | |
05-Jan-16 1:23 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Jan-16 | Payment of Exercise | 8,091 | $10.32 | $83,499.10 | (1%) 660.32K to 652.23K | 27% |
17-Jul-15 9:45 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Jul-15 | Payment of Exercise | 25,526 | $15.67 | $399,992.00 | (4%) 684.74K to 659.21K | 52% |
17-Jul-15 9:45 AM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 15-Jul-15 | Option Exercise | 33,868 | $11.81 | $399,981.00 | 5% 650.87K to 684.74K | |
22-Jun-15 4:34 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Jun-15 | Option Exercise | 20,000 | $1.20 | $24,000.00 | 3% 650.87K to 670.87K | |
22-Jun-15 4:34 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 19-Jun-15 | Market Option Sale | 20,000 | $15.02 | $300,400.00 | (3%) 670.87K to 650.87K | 50% |
03-Mar-15 3:48 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 01-Mar-15 | Payment of Exercise | 5,118 | $10.20 | $52,203.60 | (< 1%) 655.99K to 650.87K | 26% |
22-Jan-15 12:10 PM View: | BioCryst Pharmaceuticals Inc. (BCRX) | 20-Jan-15 | Payment of Exercise | 10,608 | $11.17 | $118,491.00 | (2%) 664.89K to 654.28K | 33% |